Regeneron Pharmaceuticals (REGN) CEO pay: $39.0M actually paid in FY2025
$REGN · REGENERON PHARMACEUTICALS, INC.Data through FY2025 — latest proxy filed 2026-04-24, checked for new filings 2026-08-21. Every number links to its source.
9.9× the tracked-company median CEO pay ($3.9M).
Pay vs. Performance (Compensation Actually Paid)
What the CEO was actually paid, by fiscal year
A negative figure is not pay returned. Compensation Actually Paid re-values unvested equity every year, so when a stock falls, the write-down on awards granted earlier can exceed everything granted that year. How CAP is calculated
What $100 invested was worth, company vs peer group
Pay-vs-Performance table
| FY | CEO pay on paper | CEO pay actually earned | Other top execs (avg) | Value of $100 invested since FY2020 | Same, peer group since FY2020 | Net income |
|---|---|---|---|---|---|---|
| 2025 | $7.3M | $39.0M | $14.7M | $159.77 | $200.89 | $4.50B |
| 2024 | $6.8M | -$37.7M | -$9.2M | $189.71 | $172.62 | $4.41B |
| 2023 | $8.2M | $141.1M | $46.9M | $233.91 | $159.01 | $3.95B |
| 2022 | $7.0M | $98.8M | $32.2M | $192.15 | $153.08 | $4.34B |
| 2021 | $6.5M | $123.7M | $40.2M | $168.19 | $137.47 | $8.08B |
| 2020 | $135.4M | $153.0M | $48.6M | $128.66 | $110.52 | $3.51B |
A negative figure is not pay returned. Compensation Actually Paid re-values unvested equity every year, so when a stock falls, the write-down on awards granted earlier can exceed everything granted that year. How CAP is calculated
Frequently asked
How much did the REGN CEO make in 2025?
$38,950,031 in Compensation Actually Paid (CAP) as REGENERON PHARMACEUTICALS, INC.'s CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2026-04-24.
What is pay vs. performance (PvP)?
An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.
What is Compensation Actually Paid (CAP)?
CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.
Also on REGN: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary